MARKET

GSK

GSK

GSK
NYSE

Real-time Quotes | Nasdaq Last Sale

38.35
+0.44
+1.16%
After Hours: 38.39 +0.04 +0.10% 19:46 05/07 EDT
OPEN
38.10
PREV CLOSE
37.91
HIGH
38.42
LOW
38.06
VOLUME
3.00M
TURNOVER
--
52 WEEK HIGH
43.18
52 WEEK LOW
33.26
MARKET CAP
96.48B
P/E (TTM)
13.28
1D
5D
1M
3M
1Y
5Y
Tweedy Browne CO LLC Buys Alibaba Group Holding, Fresenius Medical Care AG. ...
GuruFocus News · 1d ago
Global HIV Drugs Market Report 2021: Long-term Forecast to 2025 & 2030 - ResearchAndMarkets.com
The "HIV Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. Major players...
BusinessWire - BZX · 1d ago
Cancer Biomarker Market 2021: Key Players, Industry Size, Share, Segmentation, Comprehensive Analysis and Forecast by 2023 with Top Countries Data
May 07, 2021 (AmericaNewsHour) -- IntroductionMost healthcare professionals use diagnostic tests to clarify and support their clinical decision making....
AmericaNewsHour · 1d ago
Irritable Bowel Syndrome Drugs Market Growth to Witness a Surge by Rise in Prevalence of the Disease with a Notable CAGR during 2020 - 2029
May 07, 2021 (AmericaNewsHour) -- Research Nester published a report titled "Irritable Bowel Syndrome Drugs Market: Global Demand Analysis & Opportunity...
AmericaNewsHour · 1d ago
Global Atypical Antipsychotic Drugs Market Outlook, Industry Analysis and Prospect 2021-2026
May 07, 2021 (Heraldkeepers) -- The Atypical Antipsychotic Drugs market report provides a detailed analysis of global market size, regional and country-level...
Heraldkeepers · 1d ago
Sports & Energy Drinks Market Research Report: Size, Share, Opportunities, Challenges, Statistics, Restraints, Drivers with Key Player by 2021-2027
May 07, 2021 (Heraldkeepers) -- Market Research Engine has published a new report titled as "Sports & Energy Drinks Market Size by Application (During...
Heraldkeepers · 1d ago
Global Cervical Cancer Drugs Market Overview, Size, Share and Trends 2021
May 07, 2021 (Heraldkeepers) -- Cervical Cancer DrugsProjected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product...
Heraldkeepers · 1d ago
Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Will Reach USD 16,487.4 Million by 2026: Facts & Factors
New York, NY, May 07, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, NY, May 07, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research...
GlobeNewswire · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GSK. Analyze the recent business situations of GSK through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GSK stock price target is 47.27 with a high estimate of 53.00 and a low estimate of 37.81.
EPS
Institutional Holdings
Institutions: 1.14K
Institutional Holdings: 319.72M
% Owned: 12.71%
Shares Outstanding: 2.52B
TypeInstitutionsShares
Increased
236
39.00M
New
107
3.61M
Decreased
337
31.98M
Sold Out
103
4.23M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.86%
Pharmaceuticals & Medical Research
+1.04%
Key Executives
Non-Executive Chairman/Independent Director
Jonathan Symonds
Chief Executive Officer/Executive Director
Emma Walmsley
Chief Financial Officer/Executive Director
Iain Mackay
Corporate Executive
Roger Connor
Corporate Executive
Brian McNamara
Corporate Executive
Luke Miels
Corporate Executive
Abbas Hussain
Corporate Executive
Regis Simard
Corporate Executive
Phil Thomson
Corporate Executive
Deborah Waterhouse
Senior Vice President/General Counsel
James Ford
Senior Vice President/Director of Human Resources
Diana Conrad
Senior Vice President
Nick Hirons
Senior Vice President
Sally Jackson
Chief Technology Officer
Karenann Terrell
Chief Scientific Officer/Executive Director
Hal Barron
Other
David Redfern
Non-Executive Independent Director
Manvinder Banga
Secretary
Victoria Whyte
Non-Executive Independent Director
Charles Bancroft
Non-Executive Independent Director
Marvinder Banga
Non-Executive Independent Director
Anne Beal
Non-Executive Independent Director
Vivienne Cox
Non-Executive Independent Director
Lynn Elsenhans
Non-Executive Independent Director
Laurie Glimcher
Non-Executive Independent Director
Jesse Goodman
Non-Executive Independent Director
Judy Lewent
Non-Executive Independent Director
Urs Rohner
Declaration Date
Dividend Per Share
Ex-Div Date
05/04/2021
Dividend USD 0.5195486
05/20/2021
--
Dividend USD 0.6291689
02/18/2021
--
Dividend USD 0.5091635
11/12/2020
07/29/2020
Dividend USD 0.4854219
08/13/2020
04/29/2020
Dividend USD 0.4664139
05/14/2020
02/05/2020
Dividend USD 0.5594826
02/20/2020
--
Dividend USD 0.4923352
11/14/2019
--
Dividend USD 0.4583283
08/08/2019
--
Dividend USD 0.465536
05/16/2019
02/07/2019
Dividend USD 0.594243
02/21/2019
11/01/2018
Dividend USD 0.479
11/15/2018
07/25/2018
Dividend USD 0.491
08/09/2018
04/26/2018
Dividend USD 0.525
05/10/2018
02/07/2018
Dividend USD 0.647
02/22/2018
10/25/2017
Dividend USD 0.509
11/09/2017
07/26/2017
Dividend USD 0.496
08/09/2017
07/11/2017
Dividend USD 0.485
05/10/2017
04/11/2017
Dividend USD 0.566
02/22/2017
01/10/2017
Dividend USD 0.457
11/02/2016
10/11/2016
Dividend USD 0.462
08/10/2016
07/12/2016
Dividend USD 0.495
05/11/2016
04/12/2016
Dividend USD 1.233
02/17/2016
01/12/2016
Dividend USD 0.544
11/10/2015
09/29/2015
Dividend USD 0.572
08/12/2015
07/07/2015
Dividend USD 0.581
05/13/2015
02/04/2015
Dividend USD 0.695
02/18/2015
10/22/2014
Dividend USD 0.613
11/05/2014
07/23/2014
Dividend USD 0.648
08/06/2014
04/30/2014
Dividend USD 0.64
05/14/2014
02/05/2014
Dividend USD 0.75
02/19/2014
10/23/2013
Dividend USD 0.616
11/13/2013
07/24/2013
Dividend USD 0.553
08/07/2013
About GSK
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Webull offers kinds of GlaxoSmithKline plc (ADR) stock information, including NYSE:GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.